PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
22-Jul-2021 UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072 Olink Holding AB
22-Jul-2021 OncoArendi licenses Cresset molecule design software to advance the development of new therapeutics Cresset
22-Jul-2021 Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe Calliditas Therapeutics
22-Jul-2021 National Institute for Clinical Excellence (NICE) gives green light for pemigatinib (Pemazyre®), the first targeted therapy for those with the ‘Cinderella’ cancer, cholangiocarcinoma AMMF
22-Jul-2021 Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders Hemab
22-Jul-2021 Novo Holdings co-leads Hemab’s US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders Novo Holdings
22-Jul-2021 Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer™ enabled therapeutics Aptamer Group
22-Jul-2021 Anocca raises $47m in a Series B Financing to advance its industrialised approach to TCR-T cellular immunotherapy Anocca
22-Jul-2021 Life sciences hiring booms with vacancies for R&D professionals fuelling demand CEO of APSCo
22-Jul-2021 Dr. David Ruau joins Sensyne Health from Bayer Pharmaceuticals Sensyne Health
22-Jul-2021 Supporting Indian Biotherapeutic Companies with Antibody Development Fusion Antibodies plc
22-Jul-2021 Allergan Aesthetics Continues Partnership with Girls Inc. to Empower Confidence in High School-Aged Girls Interested in STEM Allergan Aesthetics
22-Jul-2021 VERQUVO® (vericiguat) Approved in the European Union MSD
22-Jul-2021 Institut Laue Langevin publishes new findings on SARS-CoV-2 infection mechanisms Sciad Newswire
22-Jul-2021 Relief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting RELIEF THERAPEUTICS Holdings AG
21-Jul-2021 Invitation to MorphoSys' Second Quarter and First Half 2021 Results Conference Call on July 29, 2021 MorphoSys AG
21-Jul-2021 STRATEC POSTS PRELIMINARY FIGURES FOR THE FIRST HALF AND PUBLISHES NEW SALES GUIDANCE FOR THE 2021 FINANCIAL YEAR STRATEC SE
21-Jul-2021 PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing PureTech
21-Jul-2021 The Spectra Optia(R) Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT system can now be used to provide extracorporeal photopheresis immunotherapy Terumo Blood and Cell Technologies
21-Jul-2021 Nanopharm and Leyden Labs Announce Agreement to Develop Intranasal Spray Product Candidates for Prophylactic Use Against Known and New Respiratory Viruses Nanopharm